4//SEC Filing
McCulloch Kevin 4
Accession 0001867096-25-000118
CIK 0001867096other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:26 PM ET
Size
6.9 KB
Accession
0001867096-25-000118
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Purchase
Common Stock
2025-06-13$4.38/sh+25,000$109,475→ 1,708,585 total
Holdings
- 25,000(indirect: By Spouse)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.3750 to $4.380, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0002031695
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:26 PM ET
- Size
- 6.9 KB